Aspira Women's Health Inc. (AWH)
USD 0.77
(1.97%)
USD 0.77
(1.97%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.26 Million USD | -25.55% |
| 2022 | 3.83 Million USD | -6.72% |
| 2021 | 4.1 Million USD | -19.77% |
| 2020 | 5.11 Million USD | 296.21% |
| 2019 | 1.29 Million USD | -12.76% |
| 2018 | 1.48 Million USD | -11.1% |
| 2017 | 1.66 Million USD | -9.9% |
| 2016 | 1.84 Million USD | 2834.92% |
| 2015 | 63 Thousand USD | -94.3% |
| 2014 | 1.1 Million USD | 0.0% |
| 2013 | 1.1 Million USD | 0.0% |
| 2012 | 1.1 Million USD | -84.2% |
| 2011 | 7 Million USD | 40.0% |
| 2010 | 5 Million USD | -50.0% |
| 2009 | 10 Million USD | -47.03% |
| 2008 | 18.87 Million USD | -34.15% |
| 2007 | 28.66 Million USD | 12.37% |
| 2006 | 25.51 Million USD | -20.68% |
| 2005 | 32.16 Million USD | 9.41% |
| 2004 | 29.39 Million USD | -7.75% |
| 2003 | 31.86 Million USD | 1031.57% |
| 2002 | 2.81 Million USD | 7.89% |
| 2001 | 2.61 Million USD | 210.71% |
| 2000 | 840 Thousand USD | -53.2% |
| 1999 | 1.79 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.68 Million USD | -5.79% |
| 2024 Q2 | 2.36 Million USD | -12.17% |
| 2023 Q1 | 3.51 Million USD | -8.27% |
| 2023 Q2 | 2.31 Million USD | -34.12% |
| 2023 Q3 | 2.33 Million USD | 0.95% |
| 2023 Q4 | 2.85 Million USD | 22.04% |
| 2023 FY | 2.85 Million USD | -25.55% |
| 2022 Q4 | 3.83 Million USD | 22.2% |
| 2022 FY | 3.83 Million USD | -6.72% |
| 2022 Q2 | 3.46 Million USD | -8.54% |
| 2022 Q1 | 3.78 Million USD | -7.86% |
| 2022 Q3 | 3.13 Million USD | -9.42% |
| 2021 Q3 | 3.39 Million USD | -7.25% |
| 2021 Q4 | 4.1 Million USD | 21.15% |
| 2021 FY | 4.1 Million USD | -19.77% |
| 2021 Q1 | 4.91 Million USD | -4.0% |
| 2021 Q2 | 3.65 Million USD | -25.62% |
| 2020 FY | 5.11 Million USD | 296.21% |
| 2020 Q1 | 1.24 Million USD | -3.72% |
| 2020 Q2 | 2.2 Million USD | 77.01% |
| 2020 Q3 | 2.58 Million USD | 17.39% |
| 2020 Q4 | 5.11 Million USD | 98.03% |
| 2019 FY | 1.29 Million USD | -12.76% |
| 2019 Q2 | 1.38 Million USD | -3.28% |
| 2019 Q1 | 1.43 Million USD | -3.17% |
| 2019 Q3 | 1.34 Million USD | -3.39% |
| 2019 Q4 | 1.29 Million USD | -3.58% |
| 2018 Q4 | 1.48 Million USD | -3.08% |
| 2018 Q1 | 1.62 Million USD | -2.76% |
| 2018 Q2 | 1.57 Million USD | -2.84% |
| 2018 FY | 1.48 Million USD | -11.1% |
| 2018 Q3 | 1.52 Million USD | -2.92% |
| 2017 Q3 | 1.71 Million USD | -0.41% |
| 2017 Q2 | 1.72 Million USD | -2.98% |
| 2017 FY | 1.66 Million USD | -9.9% |
| 2017 Q4 | 1.66 Million USD | -3.08% |
| 2017 Q1 | 1.77 Million USD | -3.79% |
| 2016 FY | 1.84 Million USD | 2834.92% |
| 2016 Q1 | 55 Thousand USD | -12.7% |
| 2016 Q2 | 1.93 Million USD | 3423.64% |
| 2016 Q3 | 1.88 Million USD | -2.68% |
| 2016 Q4 | 1.84 Million USD | -1.96% |
| 2015 Q4 | 63 Thousand USD | -11.27% |
| 2015 FY | 63 Thousand USD | -94.3% |
| 2015 Q3 | 71 Thousand USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | -100.0% |
| 2014 Q1 | 1.1 Million USD | 0.0% |
| 2014 Q3 | 1.1 Million USD | 0.0% |
| 2014 FY | 1.1 Million USD | 0.0% |
| 2014 Q2 | 1.1 Million USD | 0.0% |
| 2014 Q4 | 1.1 Million USD | 0.0% |
| 2013 Q2 | 1.1 Million USD | 0.0% |
| 2013 Q3 | 1.1 Million USD | 0.0% |
| 2013 Q4 | 1.1 Million USD | 0.0% |
| 2013 FY | 1.1 Million USD | 0.0% |
| 2013 Q1 | 1.1 Million USD | 0.0% |
| 2012 Q3 | 7 Million USD | 0.0% |
| 2012 Q2 | 7 Million USD | 0.0% |
| 2012 Q1 | 7 Million USD | 0.0% |
| 2012 Q4 | 1.1 Million USD | -84.2% |
| 2012 FY | 1.1 Million USD | -84.2% |
| 2011 FY | 7 Million USD | 40.0% |
| 2011 Q1 | 12 Million USD | 140.0% |
| 2011 Q3 | 7 Million USD | -41.67% |
| 2011 Q4 | 7 Million USD | 0.0% |
| 2011 Q2 | 12 Million USD | 0.0% |
| 2010 Q2 | 12 Million USD | 0.0% |
| 2010 FY | 5 Million USD | -50.0% |
| 2010 Q1 | 12 Million USD | 20.0% |
| 2010 Q4 | 5 Million USD | -58.33% |
| 2010 Q3 | 12 Million USD | 0.0% |
| 2009 Q4 | 10 Million USD | 0.0% |
| 2009 Q1 | 10 Million USD | -47.03% |
| 2009 FY | 10 Million USD | -47.03% |
| 2009 Q3 | 10 Million USD | 0.0% |
| 2009 Q2 | 10 Million USD | 0.0% |
| 2008 Q3 | 28.83 Million USD | 0.18% |
| 2008 FY | 18.87 Million USD | -34.15% |
| 2008 Q1 | 28.72 Million USD | 0.2% |
| 2008 Q2 | 28.78 Million USD | 0.2% |
| 2008 Q4 | 18.87 Million USD | -34.53% |
| 2007 FY | 28.66 Million USD | 12.37% |
| 2007 Q1 | 27.21 Million USD | 6.68% |
| 2007 Q2 | 28.55 Million USD | 4.91% |
| 2007 Q3 | 28.61 Million USD | 0.2% |
| 2007 Q4 | 28.66 Million USD | 0.2% |
| 2006 Q3 | 35.25 Million USD | 4.02% |
| 2006 FY | 25.51 Million USD | -20.68% |
| 2006 Q1 | 32.7 Million USD | 1.68% |
| 2006 Q2 | 33.88 Million USD | 3.63% |
| 2006 Q4 | 25.51 Million USD | -27.63% |
| 2005 Q2 | 29.13 Million USD | -0.31% |
| 2005 Q1 | 29.22 Million USD | -0.59% |
| 2005 Q3 | 30.33 Million USD | 4.11% |
| 2005 Q4 | 32.16 Million USD | 6.04% |
| 2005 FY | 32.16 Million USD | 9.41% |
| 2004 Q2 | 32.15 Million USD | 1.44% |
| 2004 FY | 29.39 Million USD | -7.75% |
| 2004 Q4 | 29.39 Million USD | -8.38% |
| 2004 Q1 | 31.7 Million USD | -0.51% |
| 2004 Q3 | 32.08 Million USD | -0.22% |
| 2003 Q2 | 4.58 Million USD | 72.69% |
| 2003 Q3 | 31.77 Million USD | 592.93% |
| 2003 Q4 | 31.86 Million USD | 0.3% |
| 2003 Q1 | 2.65 Million USD | -5.72% |
| 2003 FY | 31.86 Million USD | 1031.57% |
| 2002 Q3 | 2.71 Million USD | 5.85% |
| 2002 Q1 | 2.43 Million USD | -6.78% |
| 2002 FY | 2.81 Million USD | 7.89% |
| 2002 Q4 | 2.81 Million USD | 3.72% |
| 2002 Q2 | 2.56 Million USD | 5.43% |
| 2001 Q4 | 2.61 Million USD | -7.12% |
| 2001 Q3 | 2.81 Million USD | 362.17% |
| 2001 Q2 | 608 Thousand USD | -16.25% |
| 2001 FY | 2.61 Million USD | 210.71% |
| 2001 Q1 | 726 Thousand USD | -13.57% |
| 2000 Q4 | 840 Thousand USD | -14.11% |
| 2000 Q3 | 978 Thousand USD | 0.0% |
| 2000 FY | 840 Thousand USD | -53.2% |
| 1999 FY | 1.79 Million USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bionano Genomics, Inc. | 87.94 Million USD | 97.423% |
| Prenetics Global Limited | 2.36 Million USD | 4.363% |
| Star Equity Holdings, Inc. | 3.6 Million USD | 37.213% |
| CareDx, Inc | 34.22 Million USD | 93.378% |
| Exact Sciences Corporation | 2.55 Billion USD | 99.911% |
| Exagen Inc. | 23.72 Million USD | 90.447% |
| Inotiv, Inc. | 417.64 Million USD | 99.457% |
| Guardant Health, Inc. | 1.35 Billion USD | 99.833% |
| Biodesix, Inc. | 60.69 Million USD | 96.266% |
| BioNexus Gene Lab Corp. | 133.39 Thousand USD | -1598.714% |
| Precipio, Inc. | 1.11 Million USD | -103.047% |
| iSpecimen Inc. | 196.24 Thousand USD | -1054.685% |
| Natera, Inc. | 441.99 Million USD | 99.487% |
| Standard BioTools Inc. | 98.21 Million USD | 97.693% |
| 23andMe Holding Co. | 76.51 Million USD | 97.038% |
| Castle Biosciences, Inc. | 15.31 Million USD | 85.199% |
| Personalis, Inc. | 48.96 Million USD | 95.372% |
| Aclaris Therapeutics, Inc. | 426 Thousand USD | -431.925% |
| Applied DNA Sciences, Inc. | 1.23 Million USD | -83.073% |
| OpGen, Inc. | 13.04 Million USD | 82.628% |
| T2 Biosystems, Inc. | 49.49 Million USD | 95.422% |
| Myriad Genetics, Inc. | 145 Million USD | 98.437% |
| ICON Public Limited Company | 3.93 Billion USD | 99.942% |
| NeoGenomics, Inc. | 611.67 Million USD | 99.63% |
| Star Equity Holdings, Inc. | 3.6 Million USD | 37.213% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | 99.761% |
| RadNet, Inc. | 1.49 Billion USD | 99.848% |
| MDxHealth SA | 41.26 Million USD | 94.509% |
| Psychemedics Corporation | 2.29 Million USD | 1.393% |
| Illumina, Inc. | 2.26 Billion USD | 99.9% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 94.06 Million USD | 97.591% |
| DarioHealth Corp. | 29.54 Million USD | 92.329% |
| Fulgent Genetics, Inc. | 14.9 Million USD | 84.799% |
| Sera Prognostics, Inc. | 1.85 Million USD | -21.959% |
| ENDRA Life Sciences Inc. | 394.4 Thousand USD | -474.539% |
| OPKO Health, Inc. | 326.56 Million USD | 99.306% |
| Medpace Holdings, Inc. | 142.12 Million USD | 98.406% |
| Neogen Corporation | 906.23 Million USD | 99.75% |
| Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -160.029% |
| Prenetics Global Limited | 2.36 Million USD | 4.363% |
| Mainz Biomed B.V. | 7.42 Million USD | 69.464% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -43.541% |
| Trinity Biotech plc | 67.42 Million USD | 96.639% |
| Neuronetics, Inc. | 62.47 Million USD | 96.373% |
| Sotera Health Company | 2.32 Billion USD | 99.903% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -43.541% |